Skip to main content
Erschienen in: Digestive Diseases and Sciences 12/2020

27.02.2020 | Original Article

Retrospective Comparative Study of Side-by-Side and Stent-in-Stent Metal Stent Placement for Hilar Malignant Biliary Obstruction

verfasst von: Kazunaga Ishigaki, Tsuyoshi Hamada, Yousuke Nakai, Hiroyuki Isayama, Tatsuya Sato, Ryunosuke Hakuta, Kei Saito, Tomotaka Saito, Naminatsu Takahara, Suguru Mizuno, Hirofumi Kogure, Yukiko Ito, Hiroshi Yagioka, Saburo Matsubara, Dai Akiyama, Dai Mohri, Minoru Tada, Kazuhiko Koike

Erschienen in: Digestive Diseases and Sciences | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

In patients with unresectable hilar malignant biliary obstruction (MBO), bilateral metal stent placement is recommended. However, treatment selection between partially stent-in-stent (SIS) and side-by-side (SBS) methods is still controversial.

Study

Clinical outcomes of bilateral metal stent placement by SBS and SIS methods for hilar MBO were retrospectively studied in four Japanese centers. While large-cell-type uncovered metal stents were placed above the papilla in SIS, braided-type uncovered metal stents were placed across the papilla in SBS.

Results

A total of 64 patients with hilar MBO (40 SIS and 24 SBS) were included in the analysis. Technical success rate was 100% in SIS and 96% in SBS. Functional success rate was 93% in SIS and 96% in SBS. Early adverse event rates were higher in SBS (46%) than in SIS (23%), though not statistically significant (P = 0.09). Post-procedure pancreatitis was exclusively observed in SBS group (29%). Recurrent biliary obstruction rates were 48% and 43%, and the median time to recurrent biliary obstruction was 169 and 205 days in SIS and SBS, respectively.

Conclusions

Other than a trend to higher adverse event rates including post-procedure pancreatitis in SBS, clinical outcomes of SIS and SBS methods were comparable in patients with unresectable hilar MBO.
Literatur
1.
Zurück zum Zitat Perdue DG, Freeman ML, DiSario JA, et al. Plastic versus self-expanding metallic stents for malignant hilar biliary obstruction: a prospective multicenter observational cohort study. J Clin Gastroenterol. 2008;42:1040–1046.CrossRef Perdue DG, Freeman ML, DiSario JA, et al. Plastic versus self-expanding metallic stents for malignant hilar biliary obstruction: a prospective multicenter observational cohort study. J Clin Gastroenterol. 2008;42:1040–1046.CrossRef
2.
Zurück zum Zitat Sangchan A, Kongkasame W, Pugkhem A, et al. Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial. Gastrointest Endosc. 2012;76:93–99.CrossRef Sangchan A, Kongkasame W, Pugkhem A, et al. Efficacy of metal and plastic stents in unresectable complex hilar cholangiocarcinoma: a randomized controlled trial. Gastrointest Endosc. 2012;76:93–99.CrossRef
3.
Zurück zum Zitat Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, et al. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol. 2013;28:593–607.CrossRef Rerknimitr R, Angsuwatcharakon P, Ratanachu-ek T, et al. Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol. 2013;28:593–607.CrossRef
4.
Zurück zum Zitat Mukai T, Yasuda I, Nakashima M, et al. Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures: a randomized controlled trial. J Hepato-Biliary-Pancreat Sci. 2013;20:214–222.CrossRef Mukai T, Yasuda I, Nakashima M, et al. Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures: a randomized controlled trial. J Hepato-Biliary-Pancreat Sci. 2013;20:214–222.CrossRef
5.
Zurück zum Zitat Gao DJ, Hu B, Ye X, et al. Metal versus plastic stents for unresectable gallbladder cancer with hilar duct obstruction. Dig Endosc Off J Jpn Gastroenterol Endosc Soc. 2017;29:97–103. Gao DJ, Hu B, Ye X, et al. Metal versus plastic stents for unresectable gallbladder cancer with hilar duct obstruction. Dig Endosc Off J Jpn Gastroenterol Endosc Soc. 2017;29:97–103.
6.
Zurück zum Zitat Dumonceau JM, Tringali A, Papanikolaou IS, et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline—updated october 2017. Endoscopy. 2018;50:910–930.CrossRef Dumonceau JM, Tringali A, Papanikolaou IS, et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline—updated october 2017. Endoscopy. 2018;50:910–930.CrossRef
7.
Zurück zum Zitat Vienne A, Hobeika E, Gouya H, et al. Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointest Endosc. 2010;72:728–735.CrossRef Vienne A, Hobeika E, Gouya H, et al. Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointest Endosc. 2010;72:728–735.CrossRef
8.
Zurück zum Zitat Takahashi E, Fukasawa M, Sato T, et al. Biliary drainage strategy of unresectable malignant hilar strictures by computed tomography volumetry. World J Gastroenterol. 2015;21:4946–4953.CrossRef Takahashi E, Fukasawa M, Sato T, et al. Biliary drainage strategy of unresectable malignant hilar strictures by computed tomography volumetry. World J Gastroenterol. 2015;21:4946–4953.CrossRef
9.
Zurück zum Zitat Chang WH, Kortan P, Haber GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc. 1998;47:354–362.CrossRef Chang WH, Kortan P, Haber GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc. 1998;47:354–362.CrossRef
10.
Zurück zum Zitat De Palma GD, Galloro G, Siciliano S, et al. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc. 2001;53:547–553.CrossRef De Palma GD, Galloro G, Siciliano S, et al. Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study. Gastrointest Endosc. 2001;53:547–553.CrossRef
11.
Zurück zum Zitat Naitoh I, Ohara H, Nakazawa T, et al. Unilateral versus bilateral endoscopic metal stenting for malignant hilar biliary obstruction. J Gastroenterol Hepatol. 2009;24:552–557.CrossRef Naitoh I, Ohara H, Nakazawa T, et al. Unilateral versus bilateral endoscopic metal stenting for malignant hilar biliary obstruction. J Gastroenterol Hepatol. 2009;24:552–557.CrossRef
12.
Zurück zum Zitat Iwano H, Ryozawa S, Ishigaki N, et al. Unilateral versus bilateral drainage using self-expandable metallic stent for unresectable hilar biliary obstruction. Dig Endosc Off J Jpn Gastroenterol Endosc Soc. 2011;23:43–48. Iwano H, Ryozawa S, Ishigaki N, et al. Unilateral versus bilateral drainage using self-expandable metallic stent for unresectable hilar biliary obstruction. Dig Endosc Off J Jpn Gastroenterol Endosc Soc. 2011;23:43–48.
13.
Zurück zum Zitat Liberato MJ, Canena JM. Endoscopic stenting for hilar cholangiocarcinoma: efficacy of unilateral and bilateral placement of plastic and metal stents in a retrospective review of 480 patients. BMC Gastroenterol. 2012;12:103.CrossRef Liberato MJ, Canena JM. Endoscopic stenting for hilar cholangiocarcinoma: efficacy of unilateral and bilateral placement of plastic and metal stents in a retrospective review of 480 patients. BMC Gastroenterol. 2012;12:103.CrossRef
14.
Zurück zum Zitat Lee TH, Kim TH, Moon JH, et al. Bilateral versus unilateral placement of metal stents for inoperable high-grade malignant hilar biliary strictures: a multicenter, prospective, randomized study (with video). Gastrointest Endosc. 2017;86:817–827.CrossRef Lee TH, Kim TH, Moon JH, et al. Bilateral versus unilateral placement of metal stents for inoperable high-grade malignant hilar biliary strictures: a multicenter, prospective, randomized study (with video). Gastrointest Endosc. 2017;86:817–827.CrossRef
15.
Zurück zum Zitat Kogure H, Isayama H, Nakai Y, et al. Newly designed large cell Niti-S stent for malignant hilar biliary obstruction: a pilot study. Surg Endosc. 2011;25:463–467.CrossRef Kogure H, Isayama H, Nakai Y, et al. Newly designed large cell Niti-S stent for malignant hilar biliary obstruction: a pilot study. Surg Endosc. 2011;25:463–467.CrossRef
16.
Zurück zum Zitat Kogure H, Isayama H, Nakai Y, et al. High single-session success rate of endoscopic bilateral stent-in-stent placement with modified large cell Niti-S stents for malignant hilar biliary obstruction. Dig Endosc Off J Jpn Gastroenterol Endosc Soc. 2014;26:93–99. Kogure H, Isayama H, Nakai Y, et al. High single-session success rate of endoscopic bilateral stent-in-stent placement with modified large cell Niti-S stents for malignant hilar biliary obstruction. Dig Endosc Off J Jpn Gastroenterol Endosc Soc. 2014;26:93–99.
17.
Zurück zum Zitat Lee JM, Lee SH, Chung KH, et al. Small cell-versus large cell-sized metal stent in endoscopic bilateral stent-in-stent placement for malignant hilar biliary obstruction. Dig Endosc Off J Jpn Gastroenterol Endosc Soc. 2015;27:692–699. Lee JM, Lee SH, Chung KH, et al. Small cell-versus large cell-sized metal stent in endoscopic bilateral stent-in-stent placement for malignant hilar biliary obstruction. Dig Endosc Off J Jpn Gastroenterol Endosc Soc. 2015;27:692–699.
18.
Zurück zum Zitat Saleem A, Baron TH, Gostout CJ. Large-diameter therapeutic channel duodenoscope to facilitate simultaneous deployment of side-by-side self-expandable metal stents in hilar cholangiocarcinoma. Gastrointest Endosc. 2010;72:628–631.CrossRef Saleem A, Baron TH, Gostout CJ. Large-diameter therapeutic channel duodenoscope to facilitate simultaneous deployment of side-by-side self-expandable metal stents in hilar cholangiocarcinoma. Gastrointest Endosc. 2010;72:628–631.CrossRef
21.
Zurück zum Zitat Yoshida T, Hara K, Imaoka H, et al. Benefits of side-by-side deployment of 6-mm covered self-expandable metal stents for hilar malignant biliary obstructions. J Hepato-Biliary-Pancreat Sci. 2016;23:548–555.CrossRef Yoshida T, Hara K, Imaoka H, et al. Benefits of side-by-side deployment of 6-mm covered self-expandable metal stents for hilar malignant biliary obstructions. J Hepato-Biliary-Pancreat Sci. 2016;23:548–555.CrossRef
22.
Zurück zum Zitat Kawakubo K, Kawakami H, Kuwatani M, et al. Single-step simultaneous side-by-side placement of a self-expandable metallic stent with a 6-Fr delivery system for unresectable malignant hilar biliary obstruction: a feasibility study. J Hepato-Biliary-Pancreat Sci. 2015;22:151–155.CrossRef Kawakubo K, Kawakami H, Kuwatani M, et al. Single-step simultaneous side-by-side placement of a self-expandable metallic stent with a 6-Fr delivery system for unresectable malignant hilar biliary obstruction: a feasibility study. J Hepato-Biliary-Pancreat Sci. 2015;22:151–155.CrossRef
23.
Zurück zum Zitat Cosgrove N, Siddiqui AA, Adler DG, et al. A comparison of bilateral side-by-side metal stents deployed above and across the sphincter of oddi in the management of malignant hilar biliary obstruction. J Clin Gastroenterol. 2016;51:528–533.CrossRef Cosgrove N, Siddiqui AA, Adler DG, et al. A comparison of bilateral side-by-side metal stents deployed above and across the sphincter of oddi in the management of malignant hilar biliary obstruction. J Clin Gastroenterol. 2016;51:528–533.CrossRef
24.
Zurück zum Zitat Hsieh J, Thosani A, Grunwald M, et al. Serial insertion of bilateral uncovered metal stents for malignant hilar obstruction using an 8 Fr biliary system: a case series of 17 consecutive patients. Hepatobiliary Surg Nutr. 2015;4:348–353.PubMedPubMedCentral Hsieh J, Thosani A, Grunwald M, et al. Serial insertion of bilateral uncovered metal stents for malignant hilar obstruction using an 8 Fr biliary system: a case series of 17 consecutive patients. Hepatobiliary Surg Nutr. 2015;4:348–353.PubMedPubMedCentral
25.
Zurück zum Zitat Moon JH, Rerknimitr R, Kogure H, et al. Topic controversies in the endoscopic management of malignant hilar strictures using metal stent: side-by-side versus stent-in-stent techniques. J Hepato-Biliary-Pancreat Sci. 2015;22:650–656.CrossRef Moon JH, Rerknimitr R, Kogure H, et al. Topic controversies in the endoscopic management of malignant hilar strictures using metal stent: side-by-side versus stent-in-stent techniques. J Hepato-Biliary-Pancreat Sci. 2015;22:650–656.CrossRef
26.
Zurück zum Zitat Lee TH, Moon JH, Choi JH, et al. Prospective comparison of endoscopic bilateral stent-in-stent versus stent-by-stent deployment for inoperable advanced malignant hilar biliary stricture. Gastrointest Endosc. 2019;90:222–230.CrossRef Lee TH, Moon JH, Choi JH, et al. Prospective comparison of endoscopic bilateral stent-in-stent versus stent-by-stent deployment for inoperable advanced malignant hilar biliary stricture. Gastrointest Endosc. 2019;90:222–230.CrossRef
27.
Zurück zum Zitat Ito K, Sakamoto Y, Isayama H, et al. The impact of MDCT and endoscopic transpapillary mapping biopsy to predict longitudinal spread of extrahepatic cholangiocarcinoma. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2018;22:1528–1537.CrossRef Ito K, Sakamoto Y, Isayama H, et al. The impact of MDCT and endoscopic transpapillary mapping biopsy to predict longitudinal spread of extrahepatic cholangiocarcinoma. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2018;22:1528–1537.CrossRef
28.
Zurück zum Zitat Isayama H, Hamada T, Yasuda I, et al. TOKYO criteria 2014 for transpapillary biliary stenting. Dig Endosc Off J Jpn Gastroenterol Endosc Soc. 2015;27:259–264. Isayama H, Hamada T, Yasuda I, et al. TOKYO criteria 2014 for transpapillary biliary stenting. Dig Endosc Off J Jpn Gastroenterol Endosc Soc. 2015;27:259–264.
29.
Zurück zum Zitat Nakai Y, Isayama H, Tsujino T, et al. Intraductal US in the assessment of tumor involvement to the orifice of the cystic duct by malignant biliary obstruction. Gastrointest Endosc. 2008;68:78–83.CrossRef Nakai Y, Isayama H, Tsujino T, et al. Intraductal US in the assessment of tumor involvement to the orifice of the cystic duct by malignant biliary obstruction. Gastrointest Endosc. 2008;68:78–83.CrossRef
30.
Zurück zum Zitat Kongkam P, Tasneem AA, Rerknimitr R. Combination of endoscopic retrograde cholangiopancreatography and endoscopic ultrasonography-guided biliary drainage in malignant hilar biliary obstruction. Dig Endosc Off J Jpn Gastroenterol Endosc Soc. 2019;31:50–54. Kongkam P, Tasneem AA, Rerknimitr R. Combination of endoscopic retrograde cholangiopancreatography and endoscopic ultrasonography-guided biliary drainage in malignant hilar biliary obstruction. Dig Endosc Off J Jpn Gastroenterol Endosc Soc. 2019;31:50–54.
31.
Zurück zum Zitat Nakai Y, Kogure H, Isayama H, et al. Endoscopic ultrasound-guided biliary drainage for unresectable hilar malignant biliary obstruction. Clin Endosc. 2019;52:220–225.CrossRef Nakai Y, Kogure H, Isayama H, et al. Endoscopic ultrasound-guided biliary drainage for unresectable hilar malignant biliary obstruction. Clin Endosc. 2019;52:220–225.CrossRef
32.
Zurück zum Zitat Tarnasky PR, Cunningham JT, Hawes RH, et al. Transpapillary stenting of proximal biliary strictures: does biliary sphincterotomy reduce the risk of postprocedure pancreatitis? Gastrointest Endosc. 1997;45:46–51.CrossRef Tarnasky PR, Cunningham JT, Hawes RH, et al. Transpapillary stenting of proximal biliary strictures: does biliary sphincterotomy reduce the risk of postprocedure pancreatitis? Gastrointest Endosc. 1997;45:46–51.CrossRef
33.
Zurück zum Zitat Kawakubo K, Isayama H, Nakai Y, et al. Risk factors for pancreatitis following transpapillary self-expandable metal stent placement. Surg Endosc. 2012;26:771–776.CrossRef Kawakubo K, Isayama H, Nakai Y, et al. Risk factors for pancreatitis following transpapillary self-expandable metal stent placement. Surg Endosc. 2012;26:771–776.CrossRef
34.
Zurück zum Zitat Shiomi H, Matsumoto K, Isayama H. Management of acute cholangitis as a result of occlusion from a self-expandable metallic stent in patients with malignant distal and hilar biliary obstructions. Dig Endosc Off J Jpn Gastroenterol Endosc Soc. 2017;29:88–93. Shiomi H, Matsumoto K, Isayama H. Management of acute cholangitis as a result of occlusion from a self-expandable metallic stent in patients with malignant distal and hilar biliary obstructions. Dig Endosc Off J Jpn Gastroenterol Endosc Soc. 2017;29:88–93.
35.
Zurück zum Zitat Inoue T, Naitoh I, Okumura F, et al. Reintervention for stent occlusion after bilateral self-expandable metallic stent placement for malignant hilar biliary obstruction. Dig Endosc Off J Jpn Gastroenterol Endosc Soc. 2016;28:731–737. Inoue T, Naitoh I, Okumura F, et al. Reintervention for stent occlusion after bilateral self-expandable metallic stent placement for malignant hilar biliary obstruction. Dig Endosc Off J Jpn Gastroenterol Endosc Soc. 2016;28:731–737.
36.
Zurück zum Zitat Okuno M, Mukai T, Iwashita T, et al. Evaluation of endoscopic reintervention for self-expandable metallic stent obstruction after stent-in-stent placement for malignant hilar biliary obstruction. J Hepato-Biliary-Pancreat Sci. 2019;26:211–218.CrossRef Okuno M, Mukai T, Iwashita T, et al. Evaluation of endoscopic reintervention for self-expandable metallic stent obstruction after stent-in-stent placement for malignant hilar biliary obstruction. J Hepato-Biliary-Pancreat Sci. 2019;26:211–218.CrossRef
Metadaten
Titel
Retrospective Comparative Study of Side-by-Side and Stent-in-Stent Metal Stent Placement for Hilar Malignant Biliary Obstruction
verfasst von
Kazunaga Ishigaki
Tsuyoshi Hamada
Yousuke Nakai
Hiroyuki Isayama
Tatsuya Sato
Ryunosuke Hakuta
Kei Saito
Tomotaka Saito
Naminatsu Takahara
Suguru Mizuno
Hirofumi Kogure
Yukiko Ito
Hiroshi Yagioka
Saburo Matsubara
Dai Akiyama
Dai Mohri
Minoru Tada
Kazuhiko Koike
Publikationsdatum
27.02.2020
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 12/2020
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06155-z

Weitere Artikel der Ausgabe 12/2020

Digestive Diseases and Sciences 12/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.